论文信息 - 1213OCharacterization of complete responses (CRs) in patients with advanced melanoma (MEL) who received the combination of nivolumab (NIVO) and ipilimumab (IPI), NIVO or IPI alone - 字舞流文

1213OCharacterization of complete responses (CRs) in patients with advanced melanoma (MEL) who received the combination of nivolumab (NIVO) and ipilimumab (IPI), NIVO or IPI alone

D. Schadendorf | P. Ascierto | J. Wolchok | J. Larkin | F. Hodi | M. Postow | J. Grob | A. Pavlick | G. Long | D. Hogg | C. Lebbé | J. Wagstaff | J. Hassel | R. Bhore | K. Grossmann | O. Bechter | I. Márquez-Rodas | D. Walker | J. Chesney | C. Robert